Katada; Hitoshi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Katada; Hitoshi.The latest application filed is for "method for producing polypeptide hetero-oligomer".

Company Profile

8.12.20

Katada; Hitoshi - Shizuoka JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use Grant 11,454,633 - Ruike , et al. September 27, 2	2022-09-27
Fc region variant Grant 11,267,868 - Mimoto , et al. March 8, 2	2022-03-08
Method For Producing Polypeptide Hetero-oligomer App 20220010030 - Igawa; Tomoyuki ; et al.	2022-01-13
Method for producing polypeptide hetero-oligomer Grant 11,142,587 - Igawa , et al. October 12, 2	2021-10-12
Method for producing polypeptide heteromultimer Grant 11,124,576 - Igawa , et al. September 21, 2	2021-09-21
FCgammaRIIB-SPECIFIC FC REGION VARIANT App 20210261648 - Katada; Hitoshi ; et al.	2021-08-26
FcgammaRIIB-specific Fc region variant Grant 10,919,953 - Katada , et al. February 16, 2	2021-02-16
Anti-myostatin Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use App 20200317768 - RUIKE; Yoshinao ; et al.	2020-10-08
Heterodimerized polypeptide Grant 10,766,960 - Igawa , et al. Sep	2020-09-08
Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use Grant 10,738,111 - Ruike , et al. A	2020-08-11
Method For Altering Plasma Retention And Immunogenicity Of Antigen-binding Molecule App 20200199241 - Igawa; Tomoyuki ; et al.	2020-06-25
Method for altering plasma retention and immunogenicity of antigen-binding molecule Grant 10,618,965 - Igawa , et al.	2020-04-14
Pharmaceutical Composition, Antigen-binding Molecules, Treatment Method, And Screening Method App 20190382484 - IGAWA; Tomoyuki ; et al.	2019-12-19
Anti-myostatin Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use App 20180319877 - RUIKE; Yoshinao ; et al.	2018-11-08
Anti-myostatin Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use App 20180319876 - RUIKE; Yoshinao ; et al.	2018-11-08
Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use Grant 10,000,560 - Ruike , et al. June 19, 2	2018-06-19
Heterodimerized Polypeptide App 20180155451 - Mimoto; Futa ; et al.	2018-06-07
Method For Producing Polypeptide Hetero-oligomer App 20180057607 - Igawa; Tomoyuki ; et al.	2018-03-01
Heterodimerized polypeptide Grant 9,890,218 - Mimoto , et al. February 13, 2	2018-02-13
Method For Producing Polypeptide Heteromultimer App 20160229915 - Igawa; Tomoyuki ; et al.	2016-08-11
Anti-Myostatin Antibodies, Polypeptides Containing Variant Fc Regions, and Methods of Use App 20160200807 - RUIKE; Yoshinao ; et al.	2016-07-14
Antigen-Binding Molecule for Promoting Disappearance of Antigen via Fc gamma RIIB App 20160046693 - Igawa; Tomoyuki ; et al.	2016-02-18
Fc REGION VARIANT App 20160039912 - Mimoto; Futa ; et al.	2016-02-11
Heterodimerized Polypeptide App 20150344570 - Igawa; Tomoyuki ; et al.	2015-12-03
FCgammaRIIB-SPECIFIC FC REGION VARIANT App 20150299296 - Katada; Hitoshi ; et al.	2015-10-22
Heterodimerized Polypeptide App 20140199294 - Mimoto; Futa ; et al.	2014-07-17
Method For Altering Plasma Retention And Immunogenicity Of Antigen-binding Molecule App 20140105889 - Igawa; Tomoyuki ; et al.	2014-04-17
Fc-gamma-RIIb-SPECIFIC Fc ANTIBODY App 20140093496 - Mimoto; Futa ; et al.	2014-04-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.